NEW YORK (GenomeWeb) – MDxHealth announced today that it has signed on AceCGT Life Sciences Limited as the exclusive distributor of its SelectMDx for Prostate Cancer test in Hong Kong and Macao.

Under the terms of their agreement, AceCGT will send patient samples for analysis to MDxHealth's ISO-certified clinical diagnostic lab in Nijmegen, The Netherlands for analysis. Additional terms were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.